Splet纽福斯获评湖北省专精特新“小巨人”企业. 中国籍基因治疗药物获双孤儿药身份,EMA授予纽福斯NR082孤儿药认定. NFS-02!. 纽福斯眼科体内基因治疗新药获FDA孤儿药认定. 首个 … Splet29. nov. 2024 · Accuredit Therapeutics (Suzhou) Co. Ltd was established in July 2024 with its focus on intracellular targets, based on new generations of safe, efficient, and highly …
Frontera Therapeutics, Inc.
SpletPHARMCUBE interview - Dr. Xue, founder of Medilink Therapeutics. 2024-03-02 Learn more. MediLink Dosed 1st Patient in Phase I Study with ADC YL202. 2024-02-14 Learn more. … Splet联宁生物制药提供不同结构和功能的多种连接子,可用于抗体和药物的偶联的连接子。更重要的是,联宁自主开发的拥有完全知识产权的连接子可以将药物精确且可控地偶联到抗 … hover headquarters
Suzhu, China Clinical Research Trials CenterWatch
Splet©2013 TENNOR THERAPEUTICS LTD TenNor Therapeutics is a global clinical-stage company with a sharp focus on discovery and development of differentiated products to … SpletCStone Pharmaceuticals is a biopharma company focused on developing and commercializing innovative immuno-oncology and molecularly targeted drugs to address … SpletGene Therapy to Target CD19 for Chronic Lymphocytic Leukemia by Suzhou Fundamenta Therapeutics for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic … how many grams in 1 pennyweight